苍夷明目汤内服联合眼部冷湿敷治疗过敏性结膜炎临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R777.31

基金项目:


Clinical Study on Oral Administration of Cangyi Mingmu Decoction Combined with Cold-Wet Compresses on Eyes for Anaphylactic Conjunctivitis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察苍夷明目汤内服联合眼部冷湿敷对过敏性结膜炎患者临床症状及泪液因子的影响。方 法:选取68例过敏性结膜炎患者为研究对象,按随机数字表法分为对照组及研究组各34例,对照组给予 0.05%氮卓斯汀滴眼液治疗,研究组给予苍夷明目汤内服联合眼部冷湿敷治疗。2组均治疗2周。比较2组临床 疗效及不良反应发生率,比较2组治疗前后症状体征积分、泪液生化因子[嗜酸性粒细胞阳离子蛋白(ECP)、 组胺(HA)、白三烯B4(LTB4) ]、泪膜稳定性指标值[泪液分泌试验(SIT)、泪膜破裂时间(BUT) ]、泪河参 数、血清免疫球蛋白E (IgE) 水平的变化。结果:治疗2 周后,2 组症状积分、体征积分均较治疗前下 降(P<0.05),研究组症状积分、体征积分均低于对照组(P<0.05)。研究组临床疗效总有效率为94.12%,对 照组为76.47%,2组比较,差异有统计学意义(P<0.05)。治疗2周后,2组ECP、HA、LTB4水平均较治疗前 下降(P<0.05),研究组上述3项水平均低于对照组(P<0.05)。治疗2周后,2组SIT、BUT指标值均较治疗 前增加,研究组SIT、BUT指标值均大于对照组(P<0.05)。治疗2周后,2组泪河高度、泪河深度、泪河横截 面面积均较治疗前增加(P<0.05),血清IgE水平均较治疗前下降(P<0.05);研究组泪河高度、泪河深度、 泪河横截面面积均高于对照组,血清IgE水平低于对照组(P<0.05)。研究组不良反应发生率为8.82%,对照 组为14.71%,2组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:苍夷明目汤内服联合眼部冷湿 敷治疗过敏性结膜炎可改善症状及体征,提升泪膜稳定性,降低泪液炎性介质水平,缓解过敏反应,促进泪膜 功能恢复,用药安全性高。

    Abstract:

    Abstract: Objective: To observe the effect of oral administration of Cangyi Mingmu Decoction combined with cold-wet compresses on eyes on clinical symptoms and tear cytokines in patients with anaphylactic conjunctivitis. Methods:A total of 68 patients with anaphylactic conjunctivitis were selected as the study subjects and divided into the control group and the study group according to the random number table method, with 34 cases in each group. The control group was treated with 0.05% Azelastine Eye Drops, and the study group was treated with oral administration of Cangyi Mingmu Decoction combined with cold-wet compresses on eyes. Both groups were treated for 2 weeks. The clinical effects and incidence of adverse reactions were compared between the two groups,and the changes in symptom and sign scores, tear biochemical factors [eosinophil cationic protein (ECP), histamine (HA), leukotriene B4 (LTB4)],tear film stability indexes [Schirmer I test (SIT),break-up time (BUT)],lacrimal river parameters, and serum immunoglobulin E (IgE) levels were compared before and after treatment. Results : After 2 weeks of treatment,the symptom and sign scores in the two groups were decreased when compared with those before treatment (P<0.05), and the symptom and sign scores in the study group were lower than those in the control group (P<0.05). The total clinical effective rate was 94.12% in the study group, and 76.47% in the control group, the difference being significant (P<0.05). After 2 weeks of treatment, the levels of ECP, HA, and LTB4 in the two groups were decreased when compared with those before treatment (P<0.05),and the three levels in the study group were lower than those in the control group (P< 0.05). After 2 weeks of treatment,the SIT and BUT index values in the two groups were increased when compared with those before treatment,and the SIT and BUT index values in the study group were larger than those in the control group (P<0.05). After 2 weeks of treatment, the height, depth, and crosssectional areas of lacrimal rivers in the two groups were increased when compared with those before treatment (P<0.05), and serum IgE levels were decreased when compared with those before treatment (P<0.05); the height, depth, and cross-sectional area of lacrimal rivers in the study group were higher than those in the control group,and the serum IgE level was lower than that in the control group (P<0.05). The incidence of adverse reactions was 8.82% in the study group,and 14.71% in the control group,there being no significance in the difference (P>0.05). Conclusion: Oral administration of Cangyi Mingmu Decoction combined with cold-wet compresses on eyes can improve symptoms and signs of anaphylactic conjunctivitis, enhance tear film stability, reduce the levels of inflammatory mediators in tears, alleviate allergic reactions,promote tear film function recovery,and have high medication safety.

    参考文献
    相似文献
    引证文献
引用本文

邢晓青,宋欣欣,刘若琼.苍夷明目汤内服联合眼部冷湿敷治疗过敏性结膜炎临床研究[J].新中医,2024,56(9):150-155

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-05-13
  • 出版日期: